Peripheral lymphocyte subsets as predicting factors for molecular recurrence after imatinib discontinuation in a phase 2 imatinib discontinuation trial in patients with chronic myeloid leukemia Arthur Gomes Oliveira Braga; Katia Borgia Barbosa Pagnano; Marina Dal'Bó Pelegrini Campioni; Ana Beatriz Pascoal Lopes; Gislaine Oliveira Duarte; Konradin Metze; Irene Lorand-Metze;

Ponatinib in the treatment of patients with chronic myeloid leukemia and increased cardiovascular risk: A review of management strategies Tomasz Sacha; Katarzyna Krawczyk;

Circulating tumor DNA in diffuse large B-cell lymphoma: analysis of response assessment, correlation with PET/CT and clone evolution Guilherme Duffles; Jersey Heitor da Silva Maués; Fernanda Lupinacci; Luciana Guilhermino Pereira; Elisa Napolitano Ferreira; Leandro Freitas; Fernanda Niemann; Maria Emilia Seren Takahashi; Celso Darío Ramos; Maria de Lourdes L. Ferrari Chauffaille; Irene Lorand-Metze;